Genome research and microbiological diagnosis are major components of biomedical examinations. In pharmaceutical industry, such screenings of cell cultures are made to understand the functions of genes or to produce antibodies against certain diseases in a cell. A method frequently applied for fundamental research into cell biology is cell transfection. Foreign DNA or RNA molecules are introduced into a cell, thus causing a genetic modification. Lipid-similar molecules are applied most often for cell transfection.
To manufacture and distribute products, many flows of goods have to be constantly commissioned in complex conveying systems. Common material goods flow systems usually consist of rigidly defined roller conveyor sections with central control, which are integrated into a manufacturing plant in a fixed fashion: when the flow of goods increases, a change of conveying route is necessarily linked to a high effort in time and costs.
To study complex biomedical questions extensive screening experiments are necessary. In the research of widespread diseases, such as cancer or Alzheimer’s, a very high number of samples are studied under fully automated microscopes. However, on a global scale hardly any laboratories have the complete equipment and resources of interdisciplinary employees which are necessary for this. Biological methods, robot supported laboratory automation, intelligent microscopes, very large amounts of data, automatic image evaluation, and secure data exchange with other laboratories are always individual challenges. ACQUIFER AG offers a cost efficient overall solution for this.
The amcure GmbH in Karlsruhe was awarded with the second place of the Cyber One Award on June 12th, 2012 for its new active substance against pancreatic cancer. Furthermore, the amcure GmbH was awarded the renowned special prize of the state of Baden-Württemberg. The four company founders of the young spin-off of the Karlsruhe Institute of Technology work on the active substance AM001, which could open up new possibilities of treating cancer of the pancreas in the future.
The field of sensor based environment detection offers a wide and interesting spectrum of application areas. OPASCA Systems GmbH, a technology oriented spin-off of the KIT founded in 2001, has specialized in the development of intelligent sensor based systems and solutions in the area of person and object detection. The focus of the young firm is human protection in safety critical compounds, especially in medical high-tech establishments, such as with radiation therapy, x-rays, computed tomography (CT), and magnet resonance tomography (MRT).